- Home
- VECO vs CNTA Comparison
VECO vs CNTA Comparison
Compare VECO & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VECO | CNTA |
|---|---|---|
| Founded | 1945 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 3.5B |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | VECO | CNTA |
|---|---|---|
| Price | $31.76 | $26.57 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | $27.25 | ★ $40.89 |
| AVG Volume (30 Days) | 1.0M | ★ 1.1M |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.59 | N/A |
| Revenue | ★ $664,294,000.00 | N/A |
| Revenue This Year | $16.39 | N/A |
| Revenue Next Year | $12.40 | N/A |
| P/E Ratio | $51.92 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $16.92 | $9.60 |
| 52 Week High | $35.77 | $30.58 |
Technical Indicators
Market Signals| Indicator | VECO | CNTA |
|---|---|---|
| Relative Strength Index (RSI) | 52.74 | 49.00 |
| Support Level | $31.28 | $24.62 |
| Resistance Level | $32.89 | $30.29 |
| Average True Range (ATR) | 1.36 | 1.42 |
| MACD | 0.01 | -0.08 |
| Stochastic Oscillator | 51.82 | 34.75 |
Price Performance
Historical ComparisonAbout VECO Veeco Instruments Inc.
Veeco Instruments Inc is a United States-based company engaged in designing, developing, and manufacturing thin-film process equipment, mainly used for producing electronic devices. The company focuses on semiconductor process equipment that addresses a range of challenging materials engineering problems for its customers. Its products include Laser Processing Systems, Lithography Systems, Ion Beam Systems, SiC CVD Systems, MOCVD Systems, Wet Processing Systems, MBE Technologies, Atomic Layer Deposition Systems, Physical Vapor Deposition Systems, Dicing and Lapping Systems, as well as Gas & Vapor Delivery Systems. The maximum of the company's revenue is generated from sales to the Semiconductor Industry and within China.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.